TY - JOUR
T1 - Posthemorrhagic ventricular dilatation in preterm infants
T2 - When best to intervene?
AU - Leijser, Lara M
AU - Miller, Steven P.
AU - van Wezel-Meijler, Gerda
AU - Brouwer, Annemieke J
AU - Traubici, Jeffrey
AU - van Haastert, Ingrid C
AU - Whyte, Hilary E
AU - Groenendaal, Floris
AU - Kulkarni, Abhaya V
AU - Han, Kuo S
AU - Woerdeman, Peter A
AU - Church, Paige T
AU - Kelly, Edmond N
AU - Van Straaten, Henrica L M
AU - Ly, Linh G
AU - de Vries, Linda S
N1 - Funding Information:
Dr. Lara M. Leijser was awarded the Early Investigators' Exchange Program Award from the International Pediatric Research Foundation to conduct this multicenter study.
Funding Information:
L. Leijser has funding from the International Pediatric Research Foundation and the Research Training Centre, The Hospital for Sick Children. S. Miller has funding from the CIHR (Canadian Institutes of Health Research), SickKids Foundation, Kids Brain Health, and Ontario Brain Institute. G. van Wezel-Meijler, A. Brouwer, J. Traubici, I. van Haastert, H. Whyte, F. Groenendaal, A. Kulkarni, K. Han, P. Woerde-man, P. Church, E. Kelly, H. van Straaten, and L. Ly report no disclosures relevant to the manuscript. L. de Vries has funding from ZonMw (The Netherlands Organisation for Health Research and Development) and Wellcome. Go to Neurology.org/N for full disclosures.
Publisher Copyright:
© 2018 American Academy of Neurology
PY - 2018/2/20
Y1 - 2018/2/20
N2 - Objective To compare neurodevelopmental outcomes of preterm infants with and without intervention for posthemorrhagic ventricular dilatation (PHVD) managed with an “early approach” (EA), based on ventricular measurements exceeding normal (ventricular index [VI] <+2 SD/anterior horn width <6 mm) with initial temporizing procedures, followed, if needed, by permanent shunt placement, and a “late approach” (LA), based on signs of increased intracranial pressure with mostly immediate permanent intervention. Methods Observational cohort study of 127 preterm infants (gestation <30 weeks) with PHVD managed with EA (n = 78) or LA (n = 49). Ventricular size was measured on cranial ultrasound. Outcome was assessed at 18-24 months. Results Forty-nine of 78 (63%) EA and 24 of 49 (49%) LA infants received intervention. LA infants were slightly younger at birth, but did not differ from EA infants for other clinical measures. Initial intervention in the EA group occurred at younger age (29.4/33.1 week postmenstrual age; p < 0.001) with smaller ventricles (VI 2.4/14 mm >+2 SD; p < 0.01), and consisted predominantly of lumbar punctures or reservoir taps. Maximum VI in infants with/without intervention was similar in EA (3/1.5 mm >+2 SD; p = 0.3) but differed in the LA group (14/2.1 mm >+2 SD; p < 0.001). Shunt rate (20/92%; p < 0.001) and complications were lower in EA than LA group. Most EA infants had normal outcomes (>−1 SD), despite intervention. LA infants with intervention had poorer outcomes than those without (p < 0.003), with scores <−2 SD in 81%. Conclusion In preterm infants with PHVD, those with early intervention, even when eventually requiring a shunt, had outcomes indistinguishable from those without intervention, all being within the normal range. In contrast, in infants managed with LA, need for intervention predicted worse outcomes. Benefits of EA appear to outweigh potential risks. Classification of evidence This study provides Class III evidence that for preterm infants with PHVD, an EA to management results in better neurodevelopmental outcomes than a LA.
AB - Objective To compare neurodevelopmental outcomes of preterm infants with and without intervention for posthemorrhagic ventricular dilatation (PHVD) managed with an “early approach” (EA), based on ventricular measurements exceeding normal (ventricular index [VI] <+2 SD/anterior horn width <6 mm) with initial temporizing procedures, followed, if needed, by permanent shunt placement, and a “late approach” (LA), based on signs of increased intracranial pressure with mostly immediate permanent intervention. Methods Observational cohort study of 127 preterm infants (gestation <30 weeks) with PHVD managed with EA (n = 78) or LA (n = 49). Ventricular size was measured on cranial ultrasound. Outcome was assessed at 18-24 months. Results Forty-nine of 78 (63%) EA and 24 of 49 (49%) LA infants received intervention. LA infants were slightly younger at birth, but did not differ from EA infants for other clinical measures. Initial intervention in the EA group occurred at younger age (29.4/33.1 week postmenstrual age; p < 0.001) with smaller ventricles (VI 2.4/14 mm >+2 SD; p < 0.01), and consisted predominantly of lumbar punctures or reservoir taps. Maximum VI in infants with/without intervention was similar in EA (3/1.5 mm >+2 SD; p = 0.3) but differed in the LA group (14/2.1 mm >+2 SD; p < 0.001). Shunt rate (20/92%; p < 0.001) and complications were lower in EA than LA group. Most EA infants had normal outcomes (>−1 SD), despite intervention. LA infants with intervention had poorer outcomes than those without (p < 0.003), with scores <−2 SD in 81%. Conclusion In preterm infants with PHVD, those with early intervention, even when eventually requiring a shunt, had outcomes indistinguishable from those without intervention, all being within the normal range. In contrast, in infants managed with LA, need for intervention predicted worse outcomes. Benefits of EA appear to outweigh potential risks. Classification of evidence This study provides Class III evidence that for preterm infants with PHVD, an EA to management results in better neurodevelopmental outcomes than a LA.
KW - Journal Article
KW - Dilatation, Pathologic/diagnostic imaging
KW - Spinal Puncture
KW - Time-to-Treatment
KW - Humans
KW - Child, Preschool
KW - Organ Size
KW - Infant
KW - Treatment Outcome
KW - Cerebral Hemorrhage/complications
KW - Infant, Premature/growth & development
KW - Cerebral Ventricles/diagnostic imaging
KW - Cerebrospinal Fluid Shunts
KW - Echoencephalography
KW - Cohort Studies
UR - http://www.scopus.com/inward/record.url?scp=85058642159&partnerID=8YFLogxK
U2 - 10.1212/WNL.0000000000004984
DO - 10.1212/WNL.0000000000004984
M3 - Article
C2 - 29367448
SN - 0028-3878
VL - 90
SP - E698-E706
JO - Neurology
JF - Neurology
IS - 8
ER -